| Literature DB >> 35324828 |
Shunli Yang1, Muhammad Umar Zafar Khan1,2, Baohong Liu1, Muhammad Humza3, Shuanghui Yin1, Jianping Cai1,4.
Abstract
Porcine circovirus 2 (PCV2) has been recognized as an immunosuppressive pathogen. However, the crosstalk between this virus and its host cells in related signaling pathways remains poorly understood. In this study, the expression profiles of 84 genes involved in transforming growth factor-beta (TGF-β) signaling pathway were probed in PCV2b-infected primary porcine alveolar macrophages (PAMs) by using an RT2 profiler PCR array system. The protein expression levels of cytokines involved in the TGF-β signaling pathway were determined with a RayBiotech fluorescent Quantibody® porcine cytokine array system. Results showed that 48, 30, and 42 genes were differentially expressed at 1, 24, and 48 h after infection, respectively. A large number of genes analyzed by a co-expression network and implicated in transcriptional regulation and apoptosis were differentially expressed in PCV2b-infected PAMs. Among these genes, TGF-β, interleukin-10, CCAAT/enhancer-binding protein beta (C/EBPB), growth arrest, and DNA-damage-inducible 45 beta (GADD45B), and BCL2 were upregulated. By contrast, SMAD family member 1 (smad1) and smad3 were downregulated. These results suggested that the TGF-β signaling pathway was repressed in PAMs at the early onset of PCV2 infection. The inhibited apoptosis was indicated by the upregulated C/EBPB, GADD45B, and BCL2, and by the downregulated smad1 and smad3, which possibly increased the duration of PCV2 replication-permissive conditions and caused a persistent infection. Our study may provide insights into the underlying antiviral functional changes in the immune system of PCV2-infected pigs.Entities:
Keywords: mRNA; porcine circovirus 2; signaling pathway analysis; transforming growth factor-beta
Year: 2022 PMID: 35324828 PMCID: PMC8951539 DOI: 10.3390/vetsci9030101
Source DB: PubMed Journal: Vet Sci ISSN: 2306-7381
Figure 1PCV2 infection in PAMs. PCV2 in PAMs post-infection was detected by IFA based on the ODs-psdAb probe (red), the nucleus was stained with DAPI (blue).
Figure 2Gene expression patterns. Sixty-three target genes involved in the TGF-β signaling pathway were differentially expressed and were significantly different between PCV2-infected and control PAMs (A). Differentially expressed genes at each time point (B). Green: negative fold change level. Red: positive fold change level. Fold change was obtained by comparing the relative mRNA expression of target genes in PCV2-infected and uninfected control PAMs. Results are representative of three independent experiments and are presented as mean ± SE. ** represents p <0.01, * represents p < 0.05.
Differentially expressed TGF-β target genes (p < 0.05 and absolute fold change ≥1.5) between PCV2-infected and mock-infected control. Numbers in bold denote significant differential expression.
| Gene Symbol | Description | Fold Change | ||
|---|---|---|---|---|
| 1 hpi | 24 hpi | 48 hpi | ||
| Regulation of Transcription and Transcription Factor Activity | ||||
| C/EBPB | CCAAT/enhancer binding protein (C/EBP), beta | 4.96 | 2.87 | 2.55 |
| CREBBP | CREB binding protein | 8.75 | 4.33 | 3.66 |
| HMOX1 | Heme oxygenase (decycling) 1 | 7.53 | 4.49 | 3.50 |
| IL10 | Interleukin 10 | 5.97 | 4.69 | 4.68 |
| GADD45B | Growth arrest and DNA-damage-inducible, beta | 5.62 | 2.71 | 3.07 |
| NFKBIA | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 8.67 | 5.95 | 3.99 |
| RYBP | RING1 and YY1 binding protein | 3.42 | 1.59 | 1.54 |
| ID3 | Inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | 1.28 | 6.84 | 28.03 |
| RUNX1 | Runt-related transcription factor 1 | 5.78 | 1.03 | 1.76 |
| MBD1 | Methyl-CpG binding domain protein 1 | 1.95 | 1.49 | 1.65 |
| SERPINE1 | Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 4.17 | –1.12 | 1.93 |
| ID2 | Inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | 1.84 | –1.01 | 2.99 |
| ATF4 | Activating transcription factor 4 (tax-responsive enhancer element B67) | 2.08 | 1.26 | 1.15 |
| ATP1B1 | ATPase, Na+/K+ transporting, beta 1 polypeptide | 5.83 | 1.49 | −1.22 |
| BACH1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 | 5.48 | 1.06 | −1.04 |
| BHLHE40 | Basic helix-loop-helix family, member e40 | 2.76 | 1.32 | 1.43 |
| FOXO1 | Forkhead box O1 | 1.85 | 1.15 | 1.33 |
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 1.79 | −1.01 | −1.01 |
| TXNIP | Thioredoxin interacting protein | 1.55 | −1.28 | 1.19 |
| VEGFA | Vascular endothelial growth factor-A | 12.49 | 1.52 | 1.91 |
| MAPK8 | Mitogen-activated protein kinase 8 | 1.54 | −1.01 | −1.31 |
| IFRD1 | Interferon-related developmental regulator 1 | 3.87 | 1.04 | −1.25 |
| LOC396709 | Retinoic acid receptor alpha | 2.89 | 1.15 | 1.17 |
| HSP90AA1 | 90-kDa heat shock protein | 1.50 | 1.36 | 1.15 |
| LOC100620797 | Focal adhesion kinase 1-like | 1.39 | 1.39 | 1.79 |
| CTNNB1 | Catenin (cadherin-associated protein), beta 1, 88 kDa | 1.43 | 1.67 | 1.02 |
| SP1 | Sp1 transcription factor | −1.01 | 1.52 | 1.41 |
| PTGS2 | Prostaglandin G/H synthase-2 | 21.61 | 2.25 | −5.99 |
| RGS4 | Regulator of G-protein signaling 4 | 2.39 | 7.21 | −2.49 |
| FURIN | Furin-like | 2.50 | −1.18 | −1.57 |
| JARID2 | Jumonji, AT rich interactive domain 2 | 1.63 | −1.12 | −1.74 |
| EMP1 | Epithelial membrane protein 1 | 3.35 | −1.52 | −3.65 |
| TNFSF10 | Tumor necrosis factor (ligand) superfamily, member 10 | −4.98 | 3.95 | 13.72 |
| MAPK14 | Mitogen-activated protein kinase 14 | −1.95 | 1.67 | 1.63 |
| STC2 | Stanniocalcin 2 | −2.06 | −1.57 | −1.52 |
| ME2 | Malic enzyme 2, NAD(+)-dependent, mitochondrial | −1.63 | −1.18 | −1.60 |
| GTF2I | General transcription factor IIi | −3.86 | −1.07 | 1.34 |
| PPARA | Peroxisome proliferator-activated receptor alpha | −3.69 | 1.41 | 1.39 |
| Regulation of programmed cell death and apoptosis | ||||
| TGFB2 | Transforming growth factor, beta 2 | 1.76 | 3.94 | 6.36 |
| S100A8 | S100 calcium binding protein A8 | 2.91 | 14.55 | 20.75 |
| SMAD6 | SMAD family member 6 | 2.10 | −1.01 | 1.44 |
| BCL2L1 | BCL2-like 1 | 1.16 | 1.68 | 1.59 |
| CDKN1B | Cyclin-dependent kinase inhibitor 1B (p27, Kip1) | −1.22 | 1.73 | 2.20 |
| FOS | FBJ murine osteosarcoma viral oncogene homolog | −2.63 | 2.37 | 18.83 |
| FN1 | Fibronectin 1 | 1.74 | −1.12 | 3.78 |
| MMP2 | Matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | −1.96 | 1.23 | 2.88 |
| ACVR1 | Activin A receptor, type I | −1.15 | −1.58 | −1.82 |
| ACVRL1 | Activin A receptor type II-like 1 | −1.18 | −1.69 | −1.78 |
| MYC | V-myc myelocytomatosis viral oncogene homolog (avian) | −1.39 | −3.56 | −6.66 |
| HES1 | Hairy and enhancer of split 1, (Drosophila) | −1.33 | −2.15 | −3.09 |
| JUP | Junction plakoglobin | −1.30 | 1.00 | −3.28 |
| SMAD1 | SMAD family member 1 | −2.66 | −2.60 | 1.17 |
| SMAD3 | SMAD family member 3 | −2.12 | −4.28 | −1.08 |
| EPHB2 | EPH receptor B2 | −1.00 | −1.73 | −1.21 |
| No explicit function annotation | ||||
| CRYAB | Crystallin, alpha B | −1.25 | −2.25 | 1.56 |
| SREBF2 | Sterol regulatory element binding transcription factor 2 | −1.41 | −1.90 | −5.81 |
| ENG | Endoglin | 1.58 | 1.39 | 2.08 |
| BRF2 | Zinc finger protein 36, C3H type-like 2 | 1.33 | 1.21 | 1.93 |
Figure 3Expression of TGF-β at the protein level. TGF-β in the culture supernatants of control and PCV2-infected PAMs were measured by using porcine cytokine array kits. Data are expressed as pg/mL of three independent experiments. * represents p < 0.05.
Figure 4Co-expression network. A co-expression network from the expression profiles of 84 TGF-β signaling pathway-related genes was constructed. Interactive modules (A), Clustering coefficients (B).